The FDA just approved one of the first drugs for ALS. Some raise questions, but this Penn patient has no doubt.
Neurologist Toby Ferguson, formerly of Temple University and Penn Medicine, helped develop the Biogen drug, to be sold as Qalsody.
Colin Quinn injects Todd Legg with a newly approved drug for ALS at Penn's Perelman Center for Advanced Medicine. Quinn says the drug has helped stabilize Legg's condition.Read moreMonica Herndon / Staff Photographer
